Yet current research on the medications is just scratching the surface, says Marty Lerner, PhD, founder of Milestones, an eating disorder recovery program based in Florida
Once-daily liraglutide versus lixisenatide as add-on to metformin in type 2 diabetes: a 26-week randomized controlled clinical trial
This risk appears to be higher in people with a history of pancreatitis or risk factors for it, such as heavy alcohol use or gallstones
Do Not Stop Without Medical Advice If using these medications for diabetes, stopping abruptly without a replacement plan could lead to blood sugar spikes
Companies are racing to develop alternatives to injectable diabetes and weight loss drugs Injectable peptide drugs targeting the glucagon-like peptide 1 (GLP-1) receptor have had massive impact on approaches to treating diabetes and obesity, bringing huge revenue boosts to makers Novo Nordisk and Eli Lilly
Nicholls SJ, Tofe S, le Roux CW, DAlessio DA, Wiese RJ, Pavo I, Brown K, Weerakkody GJ, Zeytinoglu M, Romera IC